Colgate-Palmolive Company

Colgate-Palmolive Company Earnings Recaps

CL Consumer Staples 3 recaps
Next earnings: January 29, 2027 (estimated) · full calendar
Q3 2026 Nov 1, 2026

Colgate-Palmolive’s shares rose 2.3%, a roughly flat reaction, as the company reported growth across most categories and divisions while emphasizing that elevated cost pressures are expected to persist into early 2027. The transcript does not provide the quarter’s full sales or earnings figures or enough detail to assess the specific drivers of gross-margin performance.

Key takeaways
  • Organic sales growth was reported in all four categories and four of five divisions; emerging markets grew mid-single digits, led by India, Brazil, and China.
  • Management said base business EPS was ahead of its expectations and free cash flow was up 7%; it also reported $2.2 billion returned to shareholders year to date.
  • Hill’s had a “very strong” quarter across therapeutic and wellness, while management said it remains focused on a U.S. turnaround and reported toothpaste market-share improvement.
  • The company expects significant cost inflation to remain elevated through the fourth quarter and into early 2027; tariffs are expected to peak in the fourth quarter.
  • Management declined to provide 2027 guidance before the first quarter of next year, citing ongoing uncertainty.
Q2 2026 Aug 4, 2026

Colgate-Palmolive shares edged down 0.3% following Q2 results as modest U.S. underperformance and category softness in Pet pressured sentiment despite broad-based global growth and solid margin management.

Key takeaways
  • Organic sales grew in 4 of 5 divisions and 3 of 4 categories, led by mid-single digit growth in emerging markets including India, Brazil, Mexico, and China.
  • Hill's Pet Nutrition segment outpaced the soft pet category with 4% organic growth ex-private label disruption, though pricing was the main driver behind pet sales growth.
  • U.S. business showed signs of weakness requiring targeted category and channel actions to improve market share and heightened brand investments in H2.
  • Gross margins expanded before a modest tariff benefit; the company maintained profit and EPS growth amid significant cost inflation.
  • Free cash flow rose 18% with $1.4 billion returned to shareholders, supporting financial discipline and shareholder returns.
Q1 2026 May 3, 2026

Colgate-Palmolive shares closed up 2.2% following Q1 2026 earnings, as results were broadly in line with expectations. The company delivered organic sales growth, with momentum in emerging markets offset by continued softness in North America and a reduction in full-year gross margin guidance due to inflationary pressures.

Key takeaways
  • Organic sales growth accelerated versus Q4, led by improved volume performance in Asia Pacific and emerging markets; volume and pricing gains were reported in all four product categories and four out of five divisions (excluding the divested private label pet food business).
  • Management highlighted strong market share performance in emerging markets, credited to increased brand investment and targeted strategic interventions.
  • North America continues to experience volume/mix headwinds; while improvement is expected in Q2, the region remains a relative laggard.
  • Company reduced its expectations for 2026 gross margin, citing significant increases in raw material and packaging costs.
  • Announced an updated savings target of $200–300 million from its strategic growth and productivity program, with most benefits anticipated in 2027–2028; these savings will fund capability investments toward its 2030 strategy.